Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension in postmenopausal women: pathophysiology and management

S Oparil1

  • 1Vascular Biology and Hypertension Program, University of Alabama at Birmingham, USA.

Current Opinion in Nephrology and Hypertension
|September 1, 1995
PubMed
Summary

Over half of postmenopausal women experience hypertension, a key cardiovascular disease risk factor. Hormone replacement therapy doesn't affect blood pressure but offers other cardiovascular benefits for these women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial.

AJNR. American journal of neuroradiology·2023
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.

Journal of human hypertension·2014
Same author

Relationships between metrics of visit-to-visit variability of blood pressure.

Journal of human hypertension·2013
Same author

Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.

Journal of human hypertension·2011

Area of Science:

  • Cardiology
  • Endocrinology
  • Women's Health

Background:

  • Hypertension, especially systolic hypertension, affects over 50% of postmenopausal women.
  • This demographic faces a significant risk of cardiovascular disease.
  • Existing treatments for hypertension in this group are limited.

Purpose of the Study:

  • To evaluate the role of hormone replacement therapy (HRT) in managing cardiovascular risk factors in postmenopausal women.
  • To determine the effect of HRT on blood pressure and other cardiovascular markers.

Main Methods:

  • Review of existing literature on HRT and cardiovascular health in postmenopausal women.
  • Analysis of studies examining the impact of estrogen and estrogen/progestin therapies.

Related Experiment Videos

Main Results:

  • Hormone replacement therapy (estrogen or estrogen/progestin) does not alter blood pressure.
  • HRT demonstrates beneficial effects on other cardiovascular risk factors.

Conclusions:

  • Hormone replacement therapy is a viable option for postmenopausal women with hypertension.
  • Consider HRT for postmenopausal women to manage cardiovascular risk factors, provided no contraindications exist.